Cardiac Fibrosis Is Associated With Decreased Circulating Levels of Full-Length CILP in Heart Failure.

Park, Shuin; Ranjbarvaziri, Sara; Zhao, Peng; Ardehali, Reza

Cardiac Fibrosis Is Associated With Decreased Circulating Levels of Full-Length CILP in Heart Failure.

Park, Shuin; Ranjbarvaziri, Sara; Zhao, Peng; Ardehali, Reza.

Afiliação

Park S; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, California.
Ranjbarvaziri S; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles (UCLA), Los Angeles, California.
Zhao P; Molecular, Cellular, and Integrative Physiology Graduate Program, University of California, Los Angeles (UCLA), Los Angeles, California.
Ardehali R; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, California.

JACC Basic Transl Sci ; 5(5): 432-443, 2020 May.

Article em En | MEDLINE | ID: mdl-32478206

Palavras-chave

CFB, cardiac fibroblast; CILP, cartilage intermediate layer protein 1; COMP, cartilage oligomeric matrix protein; ECM, extracellular matrix; ELISA, enzyme-linked immunosorbent assay; Ltbp2, latent transforming growth factor-ß binding protein 2; PCR, polymerase chain reaction; RNA, ribonucleic acid; TAC, transverse aortic constriction; TGF, transforming growth factor; biomarker; cardiac fibrosis; extracellular matrix protein; heart failure

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article